Fortress Biotech, Inc.
General ticker "FBIOP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $90.6M (TTM average)
Fortress Biotech, Inc. follows the US Stock Market performance with the rate: 45.8%.
Estimated limits based on current volatility of 1.9%: low 16.14$, high 16.79$
Factors to consider:
- Total employees count: 78 (-22.8%) as of 2025
- Top business risk factors: Clinical trial failure, Regulatory and compliance, Market competition, Inability to raise capital, Profitability
- Current price 63.6% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.38$, 10.30$]
- 2026-12-31 to 2027-12-31 estimated range: [4.14$, 9.72$]
Financial Metrics affecting the FBIOP estimates:
- Positive: with PPE of -131.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: Industry earnings per price (median), % of -15.99 <= 0
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 25.20 < Shareholder equity ratio, % of 26.88 <= 34.41
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
Short-term FBIOP quotes
Long-term FBIOP plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $57.67MM | $63.26MM |
| Operating Expenses | $168.05MM | $133.48MM |
| Operating Income | $-110.38MM | $-70.22MM |
| Non-Operating Income | $-10.16MM | $36.69MM |
| Interest Expense | $9.93MM | $10.11MM |
| R&D Expense | $56.88MM | $11.90MM |
| Income(Loss) | $-120.54MM | $-33.53MM |
| Taxes | $0.31MM | $-0.62MM |
| Net Income(Loss)* | $-46.00MM | $6.82MM |
| Stockholders Equity | $22.74MM | $49.87MM |
| Inventory | $14.43MM | $9.62MM |
| Assets | $144.22MM | $185.55MM |
| Operating Cash Flow | $-80.19MM | $-65.78MM |
| Capital expenditure | $15.00MM | $0.00MM |
| Investing Cash Flow | $-15.00MM | $10.12MM |
| Financing Cash Flow | $70.64MM | $77.44MM |
| Earnings Per Share** | $-2.21 | $0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.